21-05-2025
StockTake: LTR's new appointment rises to the occasion
Don't miss out on the headlines from Stockhead. Followed categories will be added to My News.
LTR Pharma (ASX:LTP) appoints Associate Professor Darren Katz to its scientific advisory board to spearhead consultancy for Spontan, LTR's innovative nasal spray treatment for e rectile dysfunction.
Katz is a prominent urologist and medical director of Men's Health Melbourne, and will advise on R&D along with clinical development activities for Spontan and Roxus, whilst engaging with key international opinion leaders to expanding LTR's prescriber networks.
Watch the video to hear more.
This video was developed in collaboration with LTR Pharma, a Stockhead advertiser at the time of publishing.
This video does not constitute financial product advice. You should consider obtaining independent advice before making any financial.
Originally published as StockTake: LTR's new appointment rises to the occasion Stockhead
The appointment of industry trailblazer Ashok Parekh underscores the company's commitment to leveraging deep expertise as it advances its gold projects. Stockhead
Waratah Minerals has mobilised a third drill rig to its Spur gold-copper project in NSW, fuelled by a recent placement.
